Navigation Links
ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
Date:3/3/2009

p> Disclaimer

This press release contains elements that are not historical facts including, without limitation, certain statements on future expectations and other forward-looking statements. Such statements are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated.

In addition, ExonHit Therapeutics, its shareholders, and its affiliates, directors, officers, advisors and employees have not verified the accuracy of, and make no representations or warranties in relation to, statistical data or predictions contained in this press release that were taken or derived from third party sources or industry publications, and such statistical data and predictions are used in this press release for information purposes only.

Finally, this press release may be drafted in the French and English languages. In an event of differences between the texts, the French language version shall prevail.

                            EXONHIT THERAPEUTICS S.A.

                          CONSOLIDATED INCOME STATEMENT
                  (in thousands of euros, except per share data)

                                            Fiscal Year Fiscal Year
                                                   2007        2008

    Research and development revenues             5 337       4 211
    Research and development grants                  48           9
                       Total revenues             5 385       4 219

    Research and Development expenses            (8 609)     (9 878)
    Marketing and Selling expenses               (1 049)     (1 144)
    General and Administrative expenses          (3 521)     (4 592)

                   Total operating expenses     (13 179)    (15 614)

                       Loss from operations      (7 794)    (11 394)

'/>"/>
SOURCE ExonHit Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)
2. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
3. Loic Maurel Joins Exonhit Therapeutics to Become CEO
4. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
5. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
6. ExonHit Appoints a New Management Board
7. ExonHit Therapeutics - 2007 Financial Results
8. ExonHit Builds A New Organisation
9. ExonHit and bioMerieux Amend Their Strategic Partnership
10. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
11. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that the underwriters of its common ... purchase an additional 420,000 shares of common stock ... share, less underwriting discounts and commissions, in connection ... 2,800,000 shares of common stock, bringing the expected ...
(Date:7/23/2014)... 23, 2014 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic stem cell ... a multi-product healthcare company catering to the mother and child segment, ... patients across the PRC, Singapore , ... India , the Philippines and ...
(Date:7/23/2014)... Astra Nova Training , ... and pharma training services, and the Alliance ... a non-profit integrating the expertise and investments of ... global system for clinical trials, are pleased to ... expertise of industry professionals through improved and easily ...
(Date:7/22/2014)... solution of rod-shaped metal nanoparticles in water with ultrasound ... drill bits. Why? No one yet knows exactly. But ... (NIST) have clocked their speedand it,s fast. At up ... times faster than any nanoscale object submerged in liquid ... has opened up the possibility that they could be ...
Breaking Biology Technology:BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... Center, CHA General Hospital, Seoul 135-081, Korea, , ... (LCM) is an innovative technique which permits the rapid ... tissue sections. After LCM, RNA isolated from pure cell ... RNA (aRNA) for hybridization, and the differential gene expression ...
... Dr. Eugene Trogan, Ph.D., Mount Sinai School of Medicine ... Macrophage foam cells are integral in the ... complicated by the cellular heterogeneity of atherosclerotic plaque. This ... identified immunohistochemically, followed by real-time RT-PCR to selectively analyze ...
... , ... assay • LEADseeker • SPA Imaging Beads , ... In mammals, serotonin (5-hydroxytryptamine, 5-HT) is a regulator of neural transmission ... ,>The serotonin 5-HT 2C receptor is a subtype of the serotonin ...
Cached Biology Technology:Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 2Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 3Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 4Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 5Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 6Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 7Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays 8Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 2Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 3Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 4Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 5Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 6Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 7Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 8Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 9Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 10Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions 11The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 2The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 3The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 4
(Date:7/21/2014)... professor of entomology and cooperating faculty member ... University of California, Riverside, has been awarded the Silver ... Chemical Ecology ( ISCE ). , Awarded first in ... society,s highest honor. It is awarded annually to scientists ... study of chemicals that mediate interactions between living organisms. ...
(Date:7/21/2014)... weren,t ironic, but there are reasons mammoths and mastodons ... , According to research from the University of Cincinnati, ... Greater Cincinnati long before it was trendy at ... led by Brooke Crowley, an assistant professor of geology ... so much they likely were year-round residents and not ...
(Date:7/21/2014)... has issued a high health risk warning for Yellowknife ... region due to forest fires. Currently 160 wildfires ... plans for evacuation since these fires are endangering people ... area recently comes with mixed results. The rains ... to start others. , This year the Northern Territories ...
Breaking Biology News(10 mins):UC Riverside entomologist receives international honor for chemical ecology contributions 2Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3
... Montral (UdeM) and the Institute for Research in ... today announced that researchers from UdeM,s Institute for ... Squibb Company have jointly identified a small molecule ... represents a major pre-clinical milestone in the research ...
... WASHINGTON, DC A preclinical study led by ... a new oral drug shows early promise for the ... in EMBO Molecular Medicine , show ... strengthens muscle without the harsh side effects linked to ...
... students know him as an excellent economics teacher, but some ... air they breathe today is cleaner than the first breath ... this BYU professor concludes that improvements in U.S. air quality ... and disability specifically attributable to air pollution. Pope was a ...
Cached Biology News:New muscular dystrophy treatment shows promise in early study led by Children's National 2Death & disability from air pollution down 35 percent in the US 2
... The Sequi-Gen GT and PowerPac 3000 system, 220-240 ... a 38 x 50 cm vertical slab gel ... electrophoresis cell, which is capable of separating nucleic ... integral plate chamber (IPC) assembly (IPC and bonded ...
... Plus overlay agarose is used for ... IPG strips in place in PROTEAN ... is incorporated to allow monitoring of ... of 0.75% agarose in 1x Tris, ...
... The PowerPac HV high-voltage power supply, with ... increased output of 5,000 V, 500 mA, and ... monitor gel temperature between 0 and 90 degrees ... wireless data transfer. Power cord and instructions are ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
Biology Products: